JP2011209291A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011209291A5 JP2011209291A5 JP2011128088A JP2011128088A JP2011209291A5 JP 2011209291 A5 JP2011209291 A5 JP 2011209291A5 JP 2011128088 A JP2011128088 A JP 2011128088A JP 2011128088 A JP2011128088 A JP 2011128088A JP 2011209291 A5 JP2011209291 A5 JP 2011209291A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- alzheimer
- precursor
- differentially expressed
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0421639.6A GB0421639D0 (en) | 2004-09-29 | 2004-09-29 | Methods and compositions relating to alzheimer's disease |
| GB0421639.6 | 2004-09-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007534083A Division JP5483816B2 (ja) | 2004-09-29 | 2005-09-29 | アルツハイマー病に関する方法及び組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014159434A Division JP2014209132A (ja) | 2004-09-29 | 2014-08-05 | アルツハイマー病に関する方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011209291A JP2011209291A (ja) | 2011-10-20 |
| JP2011209291A5 true JP2011209291A5 (https=) | 2012-08-23 |
| JP5893269B2 JP5893269B2 (ja) | 2016-03-23 |
Family
ID=33397455
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007534083A Expired - Lifetime JP5483816B2 (ja) | 2004-09-29 | 2005-09-29 | アルツハイマー病に関する方法及び組成物 |
| JP2011128088A Expired - Lifetime JP5893269B2 (ja) | 2004-09-29 | 2011-06-08 | アルツハイマー病に関する方法及び組成物 |
| JP2014159434A Pending JP2014209132A (ja) | 2004-09-29 | 2014-08-05 | アルツハイマー病に関する方法及び組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007534083A Expired - Lifetime JP5483816B2 (ja) | 2004-09-29 | 2005-09-29 | アルツハイマー病に関する方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014159434A Pending JP2014209132A (ja) | 2004-09-29 | 2014-08-05 | アルツハイマー病に関する方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7897361B2 (https=) |
| EP (3) | EP2562545A1 (https=) |
| JP (3) | JP5483816B2 (https=) |
| AT (1) | ATE495445T1 (https=) |
| AU (1) | AU2005288689B2 (https=) |
| CA (1) | CA2580532C (https=) |
| DE (1) | DE602005025897D1 (https=) |
| DK (1) | DK2354795T3 (https=) |
| GB (1) | GB0421639D0 (https=) |
| WO (1) | WO2006035237A2 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0421639D0 (en) * | 2004-09-29 | 2004-10-27 | Proteome Sciences Plc | Methods and compositions relating to alzheimer's disease |
| GB0426859D0 (en) * | 2004-12-07 | 2005-01-12 | Proteome Sciences Plc | Diagnosis of neurodegenerative disorders |
| GB2428240A (en) | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
| ES2543341T3 (es) | 2005-09-13 | 2015-08-18 | National Research Council Of Canada | Métodos y composiciones para modular la actividad de células tumorales |
| GB0701626D0 (en) | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| AT506819B1 (de) | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
| EP2344881A4 (en) * | 2008-09-26 | 2012-03-07 | Univ Melbourne | BIOMARKER FOR MORBUS ALZHEIMER |
| IT1392551B1 (it) * | 2008-11-25 | 2012-03-09 | Bioindustry Park Del Canavese S P A | Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica |
| US20120071337A1 (en) | 2009-01-26 | 2012-03-22 | Electrophoretics Limited | Methods |
| JP2010271078A (ja) * | 2009-05-19 | 2010-12-02 | Mcbi:Kk | 認知機能障害疾患を含む精神疾患のバイオマーカーおよび該バイオマーカーを用いた認知機能障害疾患を含む精神疾患の検出方法 |
| AU2010202926B2 (en) * | 2009-09-11 | 2016-07-14 | Electrophoretics Limited | Markers and methods relating to the assessment of Alzheimer's disease |
| EA034462B1 (ru) | 2009-11-24 | 2020-02-11 | Алетиа Байотерапьютикс Инк. | Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований |
| JP6012923B2 (ja) * | 2010-12-22 | 2016-10-25 | 株式会社Ｍｃｂｉ | 認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法 |
| JP5906519B2 (ja) * | 2011-09-13 | 2016-04-20 | 国立大学法人 熊本大学 | 二次元電気泳動による蛋白質の分離方法 |
| JP2014533834A (ja) * | 2011-11-18 | 2014-12-15 | アルナイラム ファーマシューティカルズ， インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | トランスサイレチンおよびそのアイソフォームの定量化 |
| US9822170B2 (en) | 2012-02-22 | 2017-11-21 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer |
| WO2013148166A1 (en) | 2012-03-29 | 2013-10-03 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behlaf Of Arizona State University | Nanoscale process to generate reagents selective for individual protein variants |
| USRE49625E1 (en) | 2012-03-29 | 2023-08-29 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona | Nanoscale process to generate reagents selective for individual protein variants |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| US10501513B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides for the production of oncology-related proteins and peptides |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| WO2013153461A2 (en) | 2012-04-13 | 2013-10-17 | Oasis Diagnostics Corporation | Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases |
| WO2014040042A2 (en) | 2012-09-10 | 2014-03-13 | The Johns Hopkins University | Diagnostic assay for alzheimer's disease |
| WO2014055683A1 (en) * | 2012-10-03 | 2014-04-10 | The Research Foundation For The State University Of New York | Spectroscopic method for alzheimer's disease diagnosis |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| CA2902068C (en) * | 2013-02-28 | 2023-10-03 | Caprion Proteomics Inc. | Tuberculosis biomarkers and uses thereof |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| GB201310203D0 (en) * | 2013-06-07 | 2013-07-24 | Electrophoretics Ltd | Materials and methods relating to Alzheimer's disease |
| GB201310150D0 (en) * | 2013-06-07 | 2013-07-24 | Electrophoretics Ltd | Methods and compositions relating to alzheimer's disease |
| EP3039431A4 (en) * | 2013-08-27 | 2017-05-03 | CRC for Mental Health Ltd. | Method of identifying biomarkers of neurological diseases and diagnosis of neurological diseases |
| GB201322094D0 (en) | 2013-12-13 | 2014-01-29 | Electrophoretics Ltd | Methods and compositions relating to alzheimers disease |
| CA2936056A1 (en) * | 2014-01-06 | 2015-07-09 | Children's Medical Center Corporation | Biomarkers for dementia and dementia related neurological disorders |
| GB201403489D0 (en) * | 2014-02-27 | 2014-04-16 | Univ London Queen Mary | Biomarkers for endometriosis |
| US10639322B2 (en) * | 2015-03-27 | 2020-05-05 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
| US9904961B2 (en) | 2015-05-07 | 2018-02-27 | Kuwait University | System and method for determining the feedback capacity of information distributed in a complex network |
| JP6193942B2 (ja) * | 2015-09-09 | 2017-09-06 | 株式会社Ｍｃｂｉ | 認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法 |
| CN105403649B (zh) * | 2015-12-01 | 2018-03-20 | 深圳大学 | 一种检测ad的尿液多肽组ad生物标记物 |
| JP6947451B2 (ja) * | 2016-06-29 | 2021-10-13 | 学校法人自治医科大学 | バイオマーカー、診断用組成物、及び診断用キット |
| JP6947450B2 (ja) * | 2016-06-29 | 2021-10-13 | 学校法人自治医科大学 | バイオマーカー、診断用組成物、及び診断用キット |
| WO2019013341A1 (ja) * | 2017-07-14 | 2019-01-17 | 株式会社島津製作所 | 疾患検出方法 |
| JP6408087B2 (ja) * | 2017-07-25 | 2018-10-17 | 株式会社Ｍｃｂｉ | 認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法 |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| CN113024651A (zh) * | 2019-12-25 | 2021-06-25 | 中国医学科学院药物研究所 | 阿尔茨海默病生物标志物及其应用 |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| US20220260559A1 (en) * | 2020-11-04 | 2022-08-18 | Seer, Inc. | Biomarkers for diagnosing alzheimer's disease |
| CN115808492A (zh) * | 2021-09-14 | 2023-03-17 | 中国科学院深圳先进技术研究院 | 一种阿尔兹海默症生物标志物天冬酰胺及其应用 |
| EP4605754A1 (en) * | 2022-10-18 | 2025-08-27 | Immungenetics AG | Identifying a subject suffering from alzheimer's dementia or being at risk of developing alzheimer's dementia |
| CN117831756B (zh) * | 2024-03-05 | 2024-06-28 | 精智未来(广州)智能科技有限公司 | 一种认知障碍的辅助分析方法、装置、设备及存储介质 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US6342350B1 (en) * | 1997-09-05 | 2002-01-29 | The General Hospital Corporation | Alpha-2-macroglobulin diagnostic test |
| US20030211622A1 (en) | 1998-06-29 | 2003-11-13 | Roberts L. Jackson | Methods and compositions to assess oxidative brain injury |
| US20030131364A1 (en) * | 1999-04-27 | 2003-07-10 | Karen Duff | Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| JP2001249128A (ja) * | 2000-03-06 | 2001-09-14 | Ikagaku:Kk | 動脈硬化症またはアルツハイマー病の診断用キット |
| US20020174447A1 (en) * | 2001-01-23 | 2002-11-21 | Greenspan Ralph J. | Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| US6528309B2 (en) * | 2001-03-19 | 2003-03-04 | The Regents Of The University Of California | Vacuum-mediated desiccation protection of cells |
| US6451547B1 (en) * | 2001-04-25 | 2002-09-17 | Syn X Pharma | Process for differential diagnosis of Alzheimer's dementia and device therefor |
| DE10158180A1 (de) * | 2001-11-28 | 2003-09-11 | Biovision Ag | Verfahren zum Nachweis von Morbus Alzheimer und zur Unterscheidung von Morbus Alzheimer gegenüber anderen demenziellen Erkrankungen, zugehörige Peptide und deren Verwendung |
| WO2004001421A2 (en) * | 2002-06-21 | 2003-12-31 | Innogenetics N.V. | Method for the diagnosis and differential diagnosis of neurological diseases |
| US20070128596A1 (en) * | 2002-07-03 | 2007-06-07 | Roninson Igor B | Reagents and methods for identifying and modulating expression of tumor senescence genes |
| WO2004030522A2 (en) * | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
| KR100595494B1 (ko) * | 2003-02-24 | 2006-07-03 | (주) 디지탈바이오텍 | 혈액 내 베타-아밀로이드 항체 농도를 이용한 알츠하이머병 진단키트 |
| GB0421639D0 (en) * | 2004-09-29 | 2004-10-27 | Proteome Sciences Plc | Methods and compositions relating to alzheimer's disease |
-
2004
- 2004-09-29 GB GBGB0421639.6A patent/GB0421639D0/en not_active Ceased
-
2005
- 2005-09-29 EP EP12191625A patent/EP2562545A1/en not_active Withdrawn
- 2005-09-29 AU AU2005288689A patent/AU2005288689B2/en not_active Expired
- 2005-09-29 AT AT05788728T patent/ATE495445T1/de not_active IP Right Cessation
- 2005-09-29 DK DK10010288.8T patent/DK2354795T3/en active
- 2005-09-29 DE DE602005025897T patent/DE602005025897D1/de not_active Expired - Lifetime
- 2005-09-29 CA CA2580532A patent/CA2580532C/en not_active Expired - Lifetime
- 2005-09-29 WO PCT/GB2005/003756 patent/WO2006035237A2/en not_active Ceased
- 2005-09-29 EP EP10010288.8A patent/EP2354795B1/en not_active Expired - Lifetime
- 2005-09-29 EP EP05788728A patent/EP1794594B1/en not_active Expired - Lifetime
- 2005-09-29 JP JP2007534083A patent/JP5483816B2/ja not_active Expired - Lifetime
- 2005-09-29 US US11/664,076 patent/US7897361B2/en not_active Expired - Lifetime
-
2011
- 2011-01-12 US US13/005,121 patent/US20110165146A1/en not_active Abandoned
- 2011-06-08 JP JP2011128088A patent/JP5893269B2/ja not_active Expired - Lifetime
-
2014
- 2014-08-05 JP JP2014159434A patent/JP2014209132A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011209291A5 (https=) | ||
| Kraus et al. | Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease | |
| Islam et al. | Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease | |
| JP5893269B2 (ja) | アルツハイマー病に関する方法及び組成物 | |
| Lambert et al. | Proteomics: from gel based to gel free | |
| JP5873804B2 (ja) | 上皮成長因子受容体（ｅｇｆｒ）タンパク質ｓｒｍ／ｍｒｍアッセイ | |
| Sheinerman et al. | Early detection of neurodegenerative diseases: circulating brain-enriched microRNA | |
| Terracciano et al. | Asthma and COPD proteomics: current approaches and future directions | |
| US20140294839A1 (en) | Methylated Peptides Derived from Tau Protein and Their Antibodies for Diagnosis and Therapy of Alzheimer's Disease | |
| Lewczuk et al. | Neurochemical dementia diagnostics: state of the art and research perspectives | |
| JP6826543B2 (ja) | アルツハイマー病に関係する生体分子 | |
| JP2023533806A (ja) | タウオパチー又はアミロイド形成疾患を検出するための血液ベースのアッセイ | |
| Esberg et al. | Peri‐implant crevicular fluid proteome before and after adjunctive enamel matrix derivative treatment of peri‐implantitis | |
| RamachandraRao et al. | Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats | |
| Valverde et al. | Paving the way for reliable Alzheimer's disease blood diagnosis by quadruple electrochemical immunosensing | |
| Nayak et al. | Proteomics approach to identify biomarkers in neurodegenerative diseases | |
| JP6046053B2 (ja) | Ｂｃｌ−２様タンパク質１１のＳＲＭ／ＭＲＭアッセイ | |
| Thomason et al. | Reactive astrocytes associated with plaques in TgCRND8 mouse brain and in human Alzheimer brain express phosphoprotein enriched in astrocytes (PEA-15) | |
| JPWO2016143703A1 (ja) | レビー小体型認知症のバイオマーカー | |
| JP5871816B2 (ja) | インスリン受容体基質１（ｉｒｓ１）タンパク質ｓｒｍ／ｍｒｍアッセイ | |
| Chen et al. | Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach | |
| JP6668255B2 (ja) | アンドロゲン受容体（ａｒ）タンパク質のｓｒｍ／ｍｒｍアッセイ | |
| KR20190080973A (ko) | GTPase KRas 단백질(KRas)에 대한 SRM/MRM 검정 | |
| JP2019529906A5 (https=) | ||
| JP5806234B2 (ja) | 酸性およびシステインに富む分泌（ｓｐａｒｃ）タンパク質ｓｒｍ／ｍｒｍアッセイ |